Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Analytic for Hemodynamic Instability (AHI)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
Analytic for Hemodynamic Instability (AHI)
by Fifth Eye Inc.

AI Verdict

Tool A focuses on predicting hypotensive events up to 15 minutes in advance, providing detailed hemodynamic insights for immediate clinical intervention, particularly in surgical or critical care settings. Tool B, conversely, predicts broader hemodynamic instability hours ahead using continuous ECG data, offering earlier warnings for proactive patient management across in-hospital settings. While both leverage AI for hemodynamic monitoring, their distinct prediction horizons and data integration methods cater to different clinical decision-making timelines.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary concern is preventing and actively managing intraoperative hypotension or acute hemodynamic instability in critical care settings. This tool provides real-time, predictive insights up to 15 minutes in advance, offering specific guidance on preload, afterload, and contractility to enable immediate, targeted interventions.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Analytic for Hemodynamic Instability (AHI) if…

Choose Analytic for Hemodynamic Instability (AHI) if you need an early warning system for general in-hospital patients, predicting hemodynamic instability hours before traditional vital signs would indicate a problem. This AI-driven software, using continuous ECG data, is ideal for proactive patient management across wards, aiming to reduce nurse surveillance burden and prevent adverse events over a longer predictive window.

View Analytic for Hemodynamic Instability (AHI) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Analytic for Hemodynamic Instability (AHI)
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Integrates with existing hospital ECGs and can be deployed through platforms like Medical Informatics Corp.'s Sickbay™ and VitalConnect's remote patient monitoring solution.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Analytic for Hemodynamic Instability (AHI)

Tool B, as a Software as a Medical Device (SaMD) accessible via any browser-enabled device and integrating with existing in-hospital monitoring platforms, offers broader accessibility and potentially easier deployment. Its emphasis on 'easy-to-interpret visual indicators' and 'reduces nurse surveillance burden' suggests a strong focus on user-friendliness and workflow efficiency.

Clinical Value

Analytic for Hemodynamic Instability (AHI)

Tool B provides a significantly longer prediction window for hemodynamic instability, claiming 'hours ahead' and specifically 'up to 26 hours for AHI-PI' compared to Tool A's 'up to 15 minutes in advance'. This extended lead time offers clinicians a much greater opportunity for proactive intervention and potentially improved patient outcomes.

Pricing & Value

Tie

Both tools require contacting the vendor for pricing, making it impossible to compare their cost-effectiveness or overall value proposition transparently. While Tool A's reliance on specific hardware might suggest higher initial investment, this cannot be confirmed without concrete pricing details for either product.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A, backed by Edwards Lifesciences, a large and established medical device company, benefits from a robust enterprise infrastructure, explicit HIPAA compliance, and integration with its own mature monitoring platform. This provides a strong foundation for large-scale deployment, support, and long-term stability within healthcare systems.

Innovation

Analytic for Hemodynamic Instability (AHI)

While both tools leverage machine learning, Tool B demonstrates greater innovation by predicting hemodynamic instability up to 26 hours in advance using continuous ECG lead II data. This significantly extended prediction window, compared to Tool A's 15 minutes, represents a more substantial advancement in proactive patient care and early warning capabilities.

Support & Docs

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

As a product from Edwards Lifesciences, a global medical technology leader, Acumen HPI benefits from a well-established and extensive support network, comprehensive documentation, and training resources that are typically available to enterprise clients. While Tool B's vendor would offer support, the scale and breadth are unlikely to match that of a global corporation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Analytic for Hemodynamic Instability (AHI)
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Analytic for Hemodynamic Instability (AHI)
Company Edwards Lifesciences Fifth Eye
Description The Acumen Hypotension Prediction Index (HPI) software by Edwards Lifesciences uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. Fifth Eye's AHI System is an FDA-cleared, AI-driven clinical decision support software that continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings hours ahead of traditional vital signs.
Prediction Timeframe Up to 15 minutes in advance Hours ahead of traditional vital signs (up to 26 hours for AHI-PI)
Key Technology Machine learning-based algorithm AI-driven and machine learning-based technology; Real-time clinical analytics based on physiologic waveforms; Uses continuous ECG lead II data for analysis
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Critical Care, Emergency Medicine

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Analytic for Hemodynamic Instability (AHI).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI integrates with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform (and previously EV1000 Clinical Platform) via dedicated sensors, implying a more contained ecosystem. Fifth Eye's AHI System, as a Software as a Medical Device (SaMD), integrates with various in-hospital monitoring platforms like Sickbay and VitalConnect, and is accessible via any browser-enabled device, suggesting broader compatibility and potentially easier integration with existing hospital infrastructure.
Acumen HPI predicts hypotensive events up to 15 minutes in advance, utilizing continuous hemodynamic monitoring data from dedicated Acumen IQ cuff or sensor. Fifth Eye's AHI System provides early warnings for hemodynamic instability hours ahead of traditional vital signs, with its AHI-PI capable of predicting up to 26 hours in advance, primarily utilizing continuous ECG lead II data.
Acumen HPI is particularly suited for intraoperative settings and critical care, providing real-time insights into preload, afterload, and contractility to help reduce intraoperative hypotension. Fifth Eye's AHI System, with its longer predictive window and reliance on ECG data, may be more beneficial for continuous surveillance of adult in-hospital patients at risk of developing hemodynamic instability across various hospital settings, including general wards.
Acumen HPI provides a HPI parameter (0-100 likelihood score), Smart Alerts, and a Relationship View screen with detailed hemodynamic insights, which may require some familiarity with advanced hemodynamic parameters. Fifth Eye's AHI System offers easy-to-interpret visual indicators (red, yellow, green) and aims to reduce nurse surveillance burden, suggesting a potentially lower learning curve for immediate interpretation of hemodynamic stability.
Implementing Acumen HPI across multiple sites would necessitate the deployment of the Edwards Lifesciences HemoSphere or EV1000 platform and dedicated Acumen IQ sensors or cuffs in each location. Fifth Eye's AHI System, being a Software as a Medical Device, integrates with existing in-hospital monitoring platforms and is accessible via any browser-enabled device, potentially offering more flexible and less hardware-intensive multi-site deployment.
The time-to-value for both tools would depend on implementation efficiency and clinical adoption, with Acumen HPI's hardware integration potentially influencing initial setup. While specific customer references or detailed case studies on time-to-value are not explicitly provided in the descriptions, Acumen HPI has published clinical evidence demonstrating reduction in duration and severity of intraoperative hypotension. Fifth Eye has also published studies demonstrating its ability to detect patient deterioration prior to Rapid Response Team events.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or Analytic for Hemodynamic Instability (AHI)

AI Tool Finder
AI-powered search. Results may not be comprehensive.